Remote Study Start-Up Lead — Clinical Operations

Veristat; Massachusetts; A distancia; USD 110.000 - 170.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Remote working

Flexible time off

Paid holidays

Medical insurance

Tuition reimbursement

Retirement plans

Descripción de la vacante

Veristat is seeking a Study Start-Up Manager to provide operational expertise and customer-focused leadership across multiple start-up teams involved in study activation. You will oversee start-up activities for studies across country, region, or globally, ensuring adherence to GCP, ICH, SOPs and regulations.

You will lead project teams, coordinate with internal departments and external partners, and drive on-time delivery of study milestones while maintaining high-quality regulatory submissions

Formación

• Bachelor's degree in a relevant field required.
• 4 to 6 years in Clinical Operations or similar department required.
• SOCRA or ACRP certification and/or membership preferred.

Responsabilidades

• Provide operational leadership to start-up teams involved in site activation and start-up activities.
• Lead project teams to deliver start-up milestones on time and within regulatory requirements.
• Coordinate across departments and external stakeholders to ensure efficient study delivery.
• Maintain adherence to ICH/GCP, SOPs and applicable regulations.

Conocimientos

Communication skills

Leadership

Stakeholder management

Matrix environment

MS Office

Educación

Bachelor's degree in a relevant field

SOCRA or ACRP certification

Herramientas

Microsoft Office

Descripción del empleo

Veristat is seeking a Study Start-Up Manager to provide operational expertise and customer-focused leadership across multiple start-up teams involved in study activation. You will oversee start-up activities for studies across country, region, or globally, ensuring adherence to GCP, ICH, SOPs and regulations.

You will lead project teams, coordinate with internal departments and external partners, and drive on-time delivery of study milestones while maintaining high-quality regulatory submissions